id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-N-0378-0043,FDA,FDA-2012-N-0378,Acknowledgement Letter to Regensis Biomedical,Other,Acknowledgement Letter/Receipt,2012-10-19T04:00:00Z,2012,10,2012-10-19T04:00:00Z,,2012-10-19T13:23:55Z,,0,0,09000064810befd4
FDA-2012-N-0378-0042,FDA,FDA-2012-N-0378,Regenesis Biomedical Inc - Change in Classification Petition,Other,Change in Classification Petition,2012-10-19T04:00:00Z,2012,10,2012-10-19T04:00:00Z,,2012-10-23T18:23:42Z,,0,0,09000064810b201a
FDA-2012-N-0378-0008,FDA,FDA-2012-N-0378,Leroy Leslie Hamilton (re Request to FDA/CDRH to Consider Special Circumstances) Petition for Reclassification,Other,Petition(s),2012-09-13T04:00:00Z,2012,9,2012-07-06T04:00:00Z,2012-10-05T03:59:59Z,2014-11-25T01:06:49Z,,0,0,09000064810b5414
FDA-2012-N-0378-0009,FDA,FDA-2012-N-0378,"Acknowledgement Letter to MEDIcept, Inc.",Other,Acknowledgement Letter/Receipt,2012-09-13T04:00:00Z,2012,9,2012-09-13T04:00:00Z,,2012-09-13T21:27:23Z,,0,0,09000064810bf85a
FDA-2012-N-0378-0007,FDA,FDA-2012-N-0378,"MEDIcept, Inc - Change in Classification Petition",Other,Change in Classification Petition,2012-08-16T04:00:00Z,2012,8,2012-08-16T04:00:00Z,,2012-10-18T16:48:51Z,,0,0,09000064810aba3b
FDA-2012-N-0378-0004,FDA,FDA-2012-N-0378,Acknowledgement Letter to BioElectronics Corporation,Other,Acknowledgement Letter/Receipt,2012-08-14T04:00:00Z,2012,8,2012-08-14T04:00:00Z,,2012-08-14T22:53:34Z,,0,0,09000064810be89b
FDA-2012-N-0378-0005,FDA,FDA-2012-N-0378,Diapulse Corporation of America - Change in Classification Petition,Other,Change in Classification Petition,2012-08-14T04:00:00Z,2012,8,2012-08-14T04:00:00Z,,2012-10-18T16:47:58Z,,0,0,09000064810b4a4e
FDA-2012-N-0378-0003,FDA,FDA-2012-N-0378,BioElectronics Corporation - Change in Classification Petition,Other,Change in Classification Petition,2012-08-14T04:00:00Z,2012,8,2012-08-14T04:00:00Z,,2012-10-19T02:02:08Z,,0,0,09000064810b205e
FDA-2012-N-0378-0006,FDA,FDA-2012-N-0378,Acknowledgement Letter to Diapulse Corporation of America,Other,Acknowledgement Letter/Receipt,2012-08-14T04:00:00Z,2012,8,2012-08-14T04:00:00Z,,2012-08-14T22:56:15Z,,0,0,09000064810bf856
FDA-2012-N-0378-0001,FDA,FDA-2012-N-0378,Effective Date of Requirement for Premarket Approval for Shortwave Diathermy for All Other Uses,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2012-07-06T04:00:00Z,2012,7,2012-07-06T04:00:00Z,2012-10-05T03:59:59Z,2014-11-30T01:49:58Z,2012-16487,0,0,090000648107d286